A recombinant phenobarbital-inducible rat liver UDP- glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids

M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou

Centre du Medicament, URA CNRS 597, Faculte des Sciences Pharmaceutiques et Biologiques, Nancy, France.

V79 (Chinese hamster lung fibroblast) cell lines expressing a functional recombinant phenobarbital-inducible rat liver UDP- glucuronosyltransferase (UGT), i.e., UGT2B1, were established. Western blot analysis of positive colonies, using anti-rat liver UGT antibodies, revealed the presence of an immunoreactive polypeptide of the expected molecular mass of 52 kDa. The substrate specificity of the recombinant enzyme toward > 100 compounds was determined. Phenolic and alcoholic substrates included 4-methylumbelliferone, 4-hydroxybiphenyl, chloramphenicol, and testosterone, but a range of carboxylic acids of both endogenous (medium-chain saturated fatty acids, long-chain polyunsaturated fatty acids, and bile acids) and exogenous (profen nonsteroidal anti-inflammatory drugs, fibrate hypolipidemic agents, and sodium valproate) origin were also accepted, indicating that the enzyme was capable of forming both ether- and ester-type glucuronides from various structurally unrelated compounds. Determination of apparent kinetic constants for the glucuronidation by UGT2B1 of selected aglycones revealed a high maximal velocity toward the 3-position of morphine (49.3 +/- 2.2 nmol/min/mg of protein), compared with other known substrates such as 4-methylumbelliferone (2.67 +/- 0.11 nmol/min/mg of protein) or clofibric acid (0.06 +/- 0.02 nmol/min/mg of protein). To gain a better insight into the mechanisms underlying the apparently wide substrate specificity of UGT2B1, series of structurally related compounds were tested as potential substrates. The rate of glucuronidation of unbranched saturated fatty acids and omega,omega,omega-triphenylalkanoic acids increased progressively with increasing alkyl chain length and then declined, with the best substrates in these two homologous series being decanoic acid and 4,4,4- triphenylbutanoic acid, respectively. Glucuronidation of para- substituted phenols always proceeded at a higher rate than that of the corresponding para-substituted benzoic acids. This could mean that the aglycon hydroxyl group was better positioned in the enzyme active site in the case of phenols. Alternatively, if the initial interaction with the enzyme required the aglycon to be in the protonated uncharged form, then the observation could be explained by the difference in ionization between phenols and benzoic acids at the incubation pH used. The introduction of a bulky alkyl group into the para-position led to increases of up to 300-fold in the rate of glucuronidation, probably as a result of the increased aglycon lipophilicity. Finally, the enzyme showed a degree of stereo- and regiospecificity, preferring (S)- ibuprofen to the R-enantiomer (Vmax/Km, 3.06 and 1.10 microliters/min/mg of protein, respectively) and glucuronidating lithocholic acid but not hyodeoxycholic acid, which differs by only a single hydroxyl group.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 45, Issue 1, pp. 42-50, 01/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. Wiener, J.-L. Fang, N. Dossett, and P. Lazarus Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes Cancer Res., February 1, 2004; 64(3): 1190 - 1196. [Abstract] [Full Text] [PDF]

				D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4 Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79. [Abstract] [Full Text] [PDF]

				J.-L. Fang, F. A. Beland, D. R. Doerge, D. Wiener, C. Guillemette, M. M. Marques, and P. Lazarus Characterization of Benzo(a)pyrene-trans-7,8-dihydrodiol Glucuronidation by Human Tissue Microsomes and Overexpressed UDP-glucuronosyltransferase Enzymes Cancer Res., April 1, 2002; 62(7): 1978 - 1986. [Abstract] [Full Text] [PDF]

				F. K. Kessler, M. R. Kessler, D. J. Auyeung, and J. K. Ritter Glucuronidation of Acetaminophen Catalyzed by Multiple Rat Phenol UDP-Glucuronosyltransferases Drug Metab. Dispos., March 1, 2002; 30(3): 324 - 330. [Abstract] [Full Text] [PDF]

				L. Antonio, J.-P. Grillasca, J. Taskinen, E. Elovaara, B. Burchell, M.-H. Piet, B. Ethell, M. Ouzzine, S. Fournel-Gigleux, and J. Magdalou Characterization of Catechol Glucuronidation in Rat Liver Drug Metab. Dispos., February 1, 2002; 30(2): 199 - 207. [Abstract] [Full Text] [PDF]

				S. M. South, A. W. E. Wright, M. Lau, L. E. Mather, and M. T. Smith Sex-Related Differences in Antinociception and Tolerance Development following Chronic Intravenous Infusion of Morphine in the Rat: Modulatory Role of Testosterone via Morphine Clearance J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 446 - 457. [Abstract] [Full Text]

				Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9 Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360. [Abstract] [Full Text]

				K. Jemnitz, Z. Veres, K. Monostory, and L. Vereczkey Glucuronidation of Thyroxine in Primary Monolayer Cultures of Rat Hepatocytes: In Vitro Induction of UDP-Glucuronosyltranferases by Methylcholanthrene, Clofibrate, and Dexamethasone Alone and in Combination Drug Metab. Dispos., January 1, 2000; 28(1): 34 - 37. [Abstract] [Full Text]

				Q. Ren, S. E. Murphy, A. J. Dannenberg, J. Y. Park, T. R. Tephly, and P. Lazarus Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by Rat UDP-Glucuronosyltransferase 2B1 Drug Metab. Dispos., September 1, 1999; 27(9): 1010 - 1016. [Abstract] [Full Text]

				N. Terrier, E. Benoit, C. Senay, F. Lapicque, A. Radominska-Pandya, J. Magdalou, and S. Fournel-Gigleux Human and Rat Liver UDP-Glucuronosyltransferases Are Targets of Ketoprofen Acylglucuronide Mol. Pharmacol., July 1, 1999; 56(1): 226 - 234. [Abstract] [Full Text]

				D. Pless, J. N. Gouze, C. Senay, R. Herber, P. Leroy, V. Barberousse, S. Fournel-Gigleux, and J. Magdalou Characterization of the UDP-Glucuronosyltransferases Involved in the Glucuronidation of An Antithrombotic Thioxyloside in Rat and Humans Drug Metab. Dispos., May 1, 1999; 27(5): 588 - 595. [Abstract] [Full Text]

				C. J. Meunier and R. K. Verbeeck Glucuronidation of R- and S-Ketoprofen, Acetaminophen, and Diflunisal by Liver Microsomes of Adjuvant-Induced Arthritic Rats Drug Metab. Dispos., January 1, 1999; 27(1): 26 - 31. [Abstract] [Full Text]

				M. D. Green and T. R. Tephly Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins Drug Metab. Dispos., September 1, 1998; 26(9): 860 - 867. [Abstract] [Full Text]

				A. J. Hansen, Y.-H. Lee, E. Sterneck, F. J. Gonzalez, and P. I. Mackenzie C/EBPalpha Is a Regulator of the UDP Glucuronosyltransferase UGT2B1 Gene Mol. Pharmacol., June 1, 1998; 53(6): 1027 - 1033. [Abstract] [Full Text]

				M. Vargas, J. G. Lamb, and M. R. Franklin Phase II-Selective Induction of Hepatic Drug-Metabolizing Enzymes by Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione], 1,7-Phenanthroline, and 2,2'-Dipyridyl in Rats Is Not Accompanied by Induction of Intestinal Enzymes Drug Metab. Dispos., February 1, 1998; 26(2): 91 - 97. [Abstract] [Full Text]

				M. D. Green, G. Bélanger, D. W. Hum, A. Bélanger, and T. R. Tephly Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein Drug Metab. Dispos., December 1, 1997; 25(12): 1389 - 1394. [Abstract] [Full Text]

				R. Meech and P. I. Mackenzie UDP-Glucuronosyltransferase, the Role of the Amino Terminus in Dimerization J. Biol. Chem., October 24, 1997; 272(43): 26913 - 26917. [Abstract] [Full Text] [PDF]

				C. D. King, G. R. Rios, M. D. Green, P. I. Mackenzie, and T. R. Tephly Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds Drug Metab. Dispos., February 1, 1997; 25(2): 251 - 255. [Abstract] [Full Text]

				B. L. Coffman, G. R. Rios, C. D. King, and T. R. Tephly Human UGT2B7 Catalyzes Morphine Glucuronidation Drug Metab. Dispos., January 1, 1997; 25(1): 1 - 4. [Abstract] [Full Text]